Literature DB >> 18480693

A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy.

Nina Boucher1, Aida Bairam, Louise Beaulac-Baillargeon.   

Abstract

OBJECTIVES: To identify symptoms in neonates exposed to antidepressants in late pregnancy and to propose a categorization of these symptoms to help clinical assessment of antidepressant effects in exposed neonates.
METHODS: Data were extracted retrospectively from maternal and neonatal hospital charts. A total of 73 neonates exposed to antidepressant and 73 nonexposed neonates were included. Neonatal symptoms reported in the literature to be related to antidepressant exposure were collected. Multiple logistic regression analysis was used to estimate the association of neonatal symptoms and antidepressant exposure. Factorial analysis was used to regroup the neonatal symptoms.
RESULTS: Increased risk of alertness alteration (odds ratio [OR], 37;95% confidence interval [CI], 8-174), altered muscular tone (OR,20; 95% CI, 5-71), feeding and GI problems (OR, 3.8; 95% CI, 1.7-8.1), tachypnea (OR, 2.5; 95% CI, 1.1-5.3), and neurological problems (8/73 vs 0/73; P = 0.006) were found. Three statistically significant clusters of symptoms associated with antidepressant exposures emerged from the factorial analysis. Two of these clusters were similar to those described in adults for serotonergic toxicity and antidepressant discontinuation syndrome while the other was closely related to neonatal immaturity.
CONCLUSIONS: Symptoms expressed in neonates exposed to antidepressants in late pregnancy could be gathered in three clusters. This grouping could be useful to develop a new tool helping in the assessment and care of the exposed newborns.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480693     DOI: 10.1097/JCP.0b013e318173aa2e

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  14 in total

1.  Quality assessment of observational studies in psychiatry: an example  from perinatal psychiatric research.

Authors:  L E Ross; S Grigoriadis; L Mamisashvili; G Koren; M Steiner; C-L Dennis; A Cheung; P Mousmanis
Journal:  Int J Methods Psychiatr Res       Date:  2011-12       Impact factor: 4.035

Review 2.  Antidepressant use in pregnancy: a critical review focused on risks and controversies.

Authors:  N Byatt; K M Deligiannidis; M P Freeman
Journal:  Acta Psychiatr Scand       Date:  2012-12-14       Impact factor: 6.392

Review 3.  Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.

Authors:  Hanan El Marroun; Tonya White; Frank C Verhulst; Henning Tiemeier
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-27       Impact factor: 4.785

4.  Mother-infant antidepressant concentrations, maternal depression, and perinatal events.

Authors:  Dorothy Sit; James M Perel; Stephen R Wisniewski; Joseph C Helsel; James F Luther; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2011-07       Impact factor: 4.384

5.  Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.

Authors:  Megan V Smith; Anita Sung; Bhavesh Shah; Linda Mayes; Deborah S Klein; Kimberly A Yonkers
Journal:  Early Hum Dev       Date:  2012-09-20       Impact factor: 2.079

Review 6.  Antidepressant use in pregnant and postpartum women.

Authors:  Kimberly A Yonkers; Katherine A Blackwell; Janis Glover; Ariadna Forray
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

7.  Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.

Authors:  Cassidy Delaney; Jason Gien; Theresa R Grover; Gates Roe; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-09       Impact factor: 5.464

Review 8.  Pregnancy and depression: exploring a new potential treatment option.

Authors:  Deborah R Kim; Juan Gonzalez; John P O'Reardon
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

9.  When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care.

Authors:  Maria Muzik; Sheila M Marcus; Julie E Heringhausen; Heather Flynn
Journal:  Obstet Gynecol Clin North Am       Date:  2009-12       Impact factor: 2.844

10.  Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists.

Authors:  Tessa Ververs; Liset van Dijk; Somaye Yousofi; Fred Schobben; Gerard H A Visser
Journal:  BMC Health Serv Res       Date:  2009-07-17       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.